British journal of cancer
Correction: Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer.
Keun-Wook Lee, Dae Young Zang, Hyung-Don Kim, Jin-Won Kim, Bum Jun Kim, Yoon-Koo Kang, Min-Hee Ryu, Hark Kyun Kim
Published: 202510.1038/s41416-025-03267-z
No abstract available for this study.